Yayın: Sorafenib-induced pancreatitis
Tarih
Kurum Yazarları
Aydın, Taner
Eminler, Ahmet Tarık
Yıldırım, Çınar
Irak, Kader
Yazarlar
Ayyildiz, T.
Aydin, T.
Eminler, A.
Yildirim, C.
Irak, K.
Kiyici, M.
Gurel, S.
Nak, S.
Gulten, M.
Dolar, E.
Danışman
Dil
Türü
Yayıncı:
Ondokuz Mayis Universitesi
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Özet
Sorafenib is an inhibitor of multikinase proteins which is used for metastatic renal cell carcinoma and advanced stage hepatocellular carcinoma. Its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely. Five cases of acute pancreatitis have been reported in literature until date. The case we described here is the sixth case of clinically diagnosed acute pancreatitis.
Açıklama
Kaynak:
Anahtar Kelimeler:
Konusu
Tyrosine kinase inhibitor, Sorafenib, Pancreatitis, Hepatocellular carcinoma